Mearza Ali A, Aslanides Ioannis M
Emmetropia Mediterranean Eye Institute, Parodos Anapoleos 7, Heraklion, Crete GR 71201, Greece.
Expert Opin Drug Saf. 2007 Jan;6(1):27-32. doi: 10.1517/14740338.6.1.27.
Mitomycin C is a chemotherapeutic agent that acts by inhibiting DNA synthesis. Its use and application in ophthalmology has been increasing in recent years because of its modulatory effects on wound healing. Current applications include pterygium surgery, glaucoma surgery, corneal refractive surgery, cicatricial eye disease, conjunctival neoplasia and allergic eye disease. Although it has been used successfully in these conditions, it has also been associated with significant complications. This article reviews the current trends and uses of mitomycin C in the eye and its reported complications.
丝裂霉素C是一种通过抑制DNA合成起作用的化疗药物。近年来,由于其对伤口愈合的调节作用,它在眼科的使用和应用不断增加。目前的应用包括翼状胬肉手术、青光眼手术、角膜屈光手术、瘢痕性眼病、结膜肿瘤和变应性眼病。尽管它已在这些情况下成功使用,但也与严重并发症有关。本文综述了丝裂霉素C在眼部的当前趋势和用途及其报道的并发症。